ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01011322
Recruitment Status : Unknown
Verified August 2010 by Lipid Therapeutics GmbH.
Recruitment status was:  Active, not recruiting
First Posted : November 11, 2009
Last Update Posted : November 16, 2011
Sponsor:
Information provided by (Responsible Party):
Lipid Therapeutics GmbH